SCHEMBL6002344

SCHEMBL6002344

[CH2]COCc1ccc(Oc2ccccc2)cc1

nearest known ligand 0.53

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 5/20 0.53
NAAA Q02083 2/20 0.50
NR1H2 P55055 1/20 0.48
BAX Q07812 1/20 0.48
TSHR P16473 2/20 0.48
FFAR1 O14842 3/20 0.46
FFAR4 Q5NUL3 1/20 0.46
SRD5A2 P31213 1/20 0.44
MMP2 P08253 1/20 0.44
MMP3 P08254 1/20 0.44
MMP9 P14780 1/20 0.44
MAOA P21397 1/20 0.43
PPARG P37231 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8994543 0.87 TSHR (0.64) LTA4HNAAANR1H2BAXTSHR
SCHEMBL58165 0.83 TSHR (0.70) TSHR
SCHEMBL28963881 0.81 TSHR (0.67) NAAATSHR
Diphenylether SCHEMBL27567755 0.81 TSHR (0.75) LTA4HNAAANR1H2BAXTSHR
SCHEMBL2088939 0.79 LTA4H (0.57) LTA4HNAAANR1H2BAXTSHR
SCHEMBL694932 0.79 LTA4H (0.61) LTA4HNR1H2BAXTSHRFFAR1
SCHEMBL28297211 0.79 LTA4H (0.61) LTA4HNR1H2BAXTSHRFFAR1
SCHEMBL22199637 0.78 HTT (0.53) LTA4HNAAANR1H2BAXTSHR
SCHEMBL10944998 0.77 LTA4H (0.50) LTA4HNAAANR1H2BAXTSHR
SCHEMBL891493 0.77 FFAR1 (0.69) LTA4HFFAR1FFAR4MAOAPPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5017619-A Anitdiabetic HOFFMANN-LA ROCHE INC. (US) 1991-05-21 US claimed
EP-0198412-B1 PHENETHANOL AMINE DERIVATIVES F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) 1989-03-22 EP claimed
EP-1678185-A1 2,3-DIHYDRO-6-NITROIMIDAZO [2,1-B] OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2006-07-12 EP disclosed
WO-2005042542-A1 2,3-DIHYDRO-6-NITROIMIDAZO (2,1-B) OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2005-05-12 WO disclosed
US-5017619-A Anitdiabetic HOFFMANN-LA ROCHE INC. (US) 1991-05-21 US disclosed